Barbara Sommer

Charles Debattista is a distinguished psychiatrist and professor specializing in general psychiatry and psychology, with a focus on adult mental health. He is affiliated with Stanford University, where he has completed his medical education, residency, and fellowship, and has received numerous accolades for his contributions to medical education and psychiatric research. Dr. Debattista's extensive experience includes a range of publications on topics such as depression treatment and psychopharmacology, reflecting his commitment to advancing the field of psychiatry. He is recognized for his excellence in medical student education and has been honored as a fellow of the American College of Psychiatrists. Generated from the website

Dr. Axel Valle is a licensed clinical psychologist based in Palo Alto, California, specializing in cognitive behavioral therapy (CBT) for obsessive-compulsive disorder (OCD) and anxiety disorders. He brings a unique international clinical background, having completed a postdoctoral fellowship at Stanford University and earned his doctorate from The Wright Institute in Berkeley. In addition to his expertise in CBT, Dr. Valle has a master's degree in crisis and trauma from Tel Aviv University and is fluent in both English and Spanish. He is also experienced in working with high-performance athletes, providing tailored psychotherapy to meet their specific needs. Generated from the website

Dr. Kratter is an adult psychiatrist and fellowship-trained neuropsychiatrist and Clinical Assistant Professor in the Department of Psychiatry & Behavioral Sciences at Stanford University School of Medicine. He is also director of Invasive Technologies in the Stanford Brain Stimulation Laboratory. His clinical interests include the psychiatric and cognitive aspects of movement disorders like Parkinson's and Tourette's as well as depression, obsessive-compulsive disorder, and non-invasive and invasive neuromodulation for neuropsychiatric illness.His research interests focus on assessing outcomes and understanding the mechanisms of both neuromodulatory and novel pharmacological treatments.